Skip to Content Skip to Main Navigation Skip to Local Navigation Skip to Search

benralizumab - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe
AUST R: 285718
Active ingredients:
benralizumab

Dosage form:
Injection, solution

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

Deletion from market:
01 Dec 2022

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
To be replaced by: FASENRA PEN benralizumab 30mg in 1mL solution for injection prefilled pen AUST R 313902